3 results match your criteria: "Oklahoma Spine and Brain Institute[Affiliation]"
A Pivotal Randomized Clinical Trial Evaluating the Safety and Effectiveness of a Novel Hydrogel Dural Sealant as an Adjunct to Dural Repair.
Oper Neurosurg (Hagerstown)
April 2017
Carolina Neurosu-rgery & Spine Associates, Charlotte, North Carolina.
Background: A watertight dural repair is critical to minimizing the risk of postoperative complications secondary to cerebrospinal fluid (CSF) leaks.
Objective: To evaluate the safety and efficacy of a novel hydrogel, Adherus Dural Sealant, when compared with control, DuraSeal Dural Sealant System, as an adjunct to standard methods of dural repair.
Methods: In this 17-center, prospective, randomized clinical trial designed as a noninferiority, single-blinded study, 124 patients received Adherus Dural Sealant (test sealant) and 126 received DuraSeal (control).
Commentary: Surgery for nonambulatory patients with epidural spinal metastasis: is it evidence based and cost effective?
Spine J
November 2011
Oklahoma Spine and Brain Institute, 6802 S. Olympia Ave., Suite 300, Tulsa, OK 74132, USA.
Commentary on: Kim CH, Chung CK, Jahng T-A, Kim HJ. Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 2011; 11:1015-23 (in this issue).
View Article and Find Full Text PDFComplications of cervical spine manipulation therapy: 5-year retrospective study in a single-group practice.
Neurosurg Focus
December 2002
Oklahoma Spine and Brain Institute, Tulsa, Oklahoma, USA.
Article Synopsis
- The study reports on 22 patients who experienced serious complications after cervical spinal manipulation therapy (CSMT), highlighting a significant increase in complications compared to previous literature.
- During a 5-year period, researchers noted complications such as radiculopathy, myelopathy, and vertebral artery occlusion, indicating that CSMT can exacerbate existing spinal issues.
- The findings suggest higher regional incidence rates of serious complications from CSMT than previously documented, raising concerns about its safety and effectiveness in treating spinal conditions.